Evidence map›Paper›PMID 37191829›Full record

ArticleEuropean journal of epidemiology2023

The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis.

Angéline Denouel, Jean-Philippe Brandel, Danielle Seilhean, Jean-Louis Laplanche, Alexis Elbaz, Stéphane Haik

Open access · hybridAbstract read
In one paragraph

Article in European journal of epidemiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Declining incidence of Parkinson's disease in Israel (2002-2021).Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Creutzfeldt-Jakob disease and other prion diseases.Nature reviews. Disease primers · 2024
    Review
  7. Article
  8. Prospective 25-year surveillance of prion diseases in France, 1992 to 2016: a slow waning of epidemics and an increase in observed sporadic forms.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Angéline DenouelCNRS UMR 7225, INSERM U1127, Paris Brain Institute, Sorbonne Universités, Paris, France. angeline.denouel@icm-institute.org.
Jean-Philippe BrandelCNRS UMR 7225, INSERM U1127, Paris Brain Institute, Sorbonne Universités, Paris, France.
Danielle SeilheanCNRS UMR 7225, INSERM U1127, Paris Brain Institute, Sorbonne Universités, Paris, France.
Jean-Louis LaplancheDépartement de Biochimie et Biologie Moléculaire, Hôpitaux Lariboisière-Fernand Widal, Paris, France.
Alexis ElbazUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, Gustave Roussy, Inserm, U1018, Team « Exposome, Heredity, Cancer, and Health », CESP, Villejuif, 94807, France.
Stéphane HaikCNRS UMR 7225, INSERM U1127, Paris Brain Institute, Sorbonne Universités, Paris, France.
Centre National de la Recherche Scientifique · FRInstitut du Cerveau · FRSorbonne Université · FRUniversité Paris Cité · FRUniversité Paris-Saclay · FR

Funding

Institut de Veille Sanitaire Institut de Veille Sanitaire
6 · The paper itself

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common form of prion diseases. The causes of sCJD are still unknown and exogenous factors may play a role. Worldwide, the number of patients with sCJD has progressively increased over time. This increase can be partly explained by increasing life expectancy and better case ascertainment, but a true increase in the number of sCJD cases cannot be excluded. We estimated mortality rates from sCJD in France (1992-2016) and studied variation in mortality rates by age, period, and time.We included all cases aged 45-89 years old who died with a probable/definite sCJD diagnosis based on the French national surveillance network. We used age-period-cohort (APC) Poisson regression models to study variation in mortality rates by sex, age, period, and time.A total of 2475 sCJD cases aged 45-89 years were included. Mortality rates increased with age, reached a peak between 75 and 79 years, and decreased thereafter. Mortality rates were higher in women than men at younger ages and lower at older ages. The full APC model with a sex×age interaction provided the best fit to the data, thus in favour of sex, age, period, and cohort effects on mortality rates. In particular, mortality rates increased progressively with successive birth cohorts.Based on 25 years of active surveillance in France, we show evidence for sex, age, period, and cohort effects on sCJD mortality. The identification of cohort effects suggests that environmental exposures may play a role in sCJD etiology.

Indexed as

Creutzfeldt-Jakob SyndromeAgedAged, 80 and overCohort StudiesDeathFemaleFranceHumansMaleMiddle AgedAge-period-cohort modelPrionSporadic Creutzfeldt-Jakob diseaseTemporal trend

Identifiers

PMID37191829
PMCPMC10276107
OpenAlexW4376641577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.